ZOFIXIME

This brand name is authorized in Nigeria.

Active ingredients

The drug ZOFIXIME contains one active pharmaceutical ingredient (API):

1	Cefixime UNII 97I1C92E55 - CEFIXIME
	Cefixime is an oral third generation cephalosporin which has marked in vitro bactericidal activity against a wide variety of Gram-positive and Gram-negative organisms.
	Read more about Cefixime

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-7310	Tablet	Zofixime 400 mg Tablets TAB 400 mg 1 x 10's (in Alu-PVC blister)	Film-coated tablet. Convex, off-white, film-coated tablets engraved with 'ORO' on one side	06/07/2023
A4-8031	Powder for suspension	Zofixime Powder for Oral Suspension 100 mg PWD_F_SOL 100 mg/5 mL	Powder for Oral Suspension	20/12/2019

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD08	Cefixime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-7310, A4-8031